Bank of Montreal
MRNS

Bank of Montreal’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Bank of Montreal’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-429,600
Closed -$608K – 4053
2024
Q3 		$608K Buy
+429,600
New +$600K ﹤0.01% 2286
2023
Q3 		– Sell
-188,722
Closed -$2.06M – 4348
2023
Q2 		$2.06M Sell
188,722
-163,106
-46% -$1.4M ﹤0.01% 1803
2023
Q1 		$2.53M Sell
351,828
-68,572
-16% -$430K ﹤0.01% 1581
2022
Q4 		$1.68M Buy
420,400
+68,700
+20% +$338K ﹤0.01% 1869
2022
Q3 		$2.48K Hold
351,700
– – ﹤0.01% 1708
2022
Q2 		$1.79K Hold
351,700
– – ﹤0.01% 1951
2022
Q1 		$3.63M Sell
351,700
-14,600
-4% -$145K ﹤0.01% 1628
2021
Q4 		$4.52M Sell
366,300
-49,523
-12% -$572K ﹤0.01% 1270
2021
Q3 		$4.79M Buy
+415,823
New +$5.72M ﹤0.01% 1654
2021
Q2 		– Sell
-865
Closed -$13K – 5120
2021
Q1 		$13K Sell
865
-2,983
-78% -$43.1K ﹤0.01% 4250
2020
Q4 		$47K Buy
3,848
+2,788
+263% +$38.9K ﹤0.01% 3981
2020
Q3 		$15K Sell
1,060
-623
-37% -$5.38K ﹤0.01% 3960
2020
Q2 		$16K Buy
+1,683
New +$15.5K ﹤0.01% 3962
2020
Q1 		– Sell
-1,641
Closed -$14K – 4849
2019
Q4 		$14K Buy
1,641
+544
+50% +$3.05K ﹤0.01% 4478
2019
Q3 		$7K Buy
1,097
+44
+4% +$355 ﹤0.01% 4507
2019
Q2 		$17K Buy
1,053
+969
+1,154% +$16.8K ﹤0.01% 4276
2019
Q1 		$1K Sell
84
-44
-34% -$634 ﹤0.01% 4225
2018
Q4 		$1K Buy
128
+65
+103% +$1.31K ﹤0.01% 4580
2018
Q3 		$3K Sell
63
-2
-3% -$57 ﹤0.01% 4272
2018
Q2 		$2K Buy
+65
New +$1.44K ﹤0.01% 4422

Other funds holding MRNS

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of Montreal's MRNS Position: Q4 2024 in Review

Bank of Montreal sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q4 2024, closing a stake of 429,600 shares — an estimated $608K sold.

Bank of Montreal first reported a position in MRNS in Q2 2018 and held it in 20 quarters. The position peaked at $4.79M in Q3 2021. 53 funds tracked by Wall St. Rank hold MRNS as of Q4 2024.

  • Bank of Montreal reported no remaining Marinus Pharmaceuticals, Inc position as of Q4 2024 after selling out during the quarter.
  • Bank of Montreal sold 429,600 Marinus Pharmaceuticals, Inc shares in Q4 2024, an estimated $608K.
  • Bank of Montreal first reported a position in Marinus Pharmaceuticals, Inc in Q2 2018 and held it in 20 quarters.
  • Bank of Montreal's Marinus Pharmaceuticals, Inc position peaked at $4.79M in Q3 2021.
  • 53 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q4 2024.

Based on Bank of Montreal's 13F filing for Q4 2024, filed 13 Feb 2025.